Home >> Report Store >> Healthcare >> Genitourinary Therapeutics Market Report>

Genitourinary Therapeutics Market Size Worth $30.2 Billion By 2025 | CAGR: 1.2%

Published Date : 22 / 07 / 17 | Report Format: PDF

The global genitourinary therapeutics market is expected to grow at growth rate of 1.2% to reach USD 30.2 billion by 2025. The continuous increase in the prevalence of genitourinary disorders across the globe stimulates the market growth significantly. In addition, rising research and development activities coupled with a vast array of pipeline drugs with a high probability of regulatory approval is anticipated to be a high impact growth rendering driver for this industry. However, patient expiry and the influx of generic therapeutics pull back the industry growth to some extent. Companies namely GlaxoSmithKline, Bayer, Abbott, Roche, and Novartis are actively operating in this market. The industry is characterized by the presence of multinational companies as well as the presence of small players is noticeable too. For instance, in February 2017, Argos Therapeutics participated in 2017 Genitourinary Cancers Symposium cosponsored by the American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), and Society of Urologic Oncology (SUO). The company aimed to present its product offering among the investors through such participation.

Key Takeaways:

  • Of the different indications, prostate cancer constitutes the largest share. In 2017, this segment has recorded USD 7.38 billion revenue i.e. over 25% share of the total market
  • Availability of wide range of effective therapeutics such as radiopharmaceuticals, anti-neoplastic agents and immunotherapy that can impede disease progression and heightened survival chances, support the segment growth.
  • Furthermore, the introduction of advanced formulation techniques by key players’ drive the prostate cancer segment to great extent. For instance, the launch of Xofigo (Radium-223) to treat advanced prostate cancer.
  • Renal cancer is considered to be the second largest revenue generating segment owing to the increasing incidences of this disease. According to the World Health Organization (WHO), urinary tract infection is the leading cause of morbidity and healthcare expenditure in patients of all age groups.
  • Genitourinary conditions such as interstitial cystitis and bladder cancer are projected to grow with a lucrative CAGR over the forecast period
  • Based on products, urological and hormonal therapy captured the highest revenue share due to its high efficiency and cost-effectiveness. In 2017, these segments accounted for more than 50% revenue share collectively.
  • Additionally, strong demand for these segment is backed by growing demand for therapeutics such as Edex(Urological), Myrbetriq (Urological), Lupron(Hormonal drug), Xtandi(Hormonal drug) and Zytiga(Hormonal drug)
  • Regionally, North America dominated the global industry with 42.6% share in 2017. Increasing prevalence of genitourinary diseases coupled with favorable government initiatives augments the regional development.


  • The report presents macro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
  • Thorough analysis of relevant statistical data to estimate the market paradigms
  • Exceptional understanding of region and country specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
  • Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation


  • Prostate Cancer
  • Benign Prostatic Hyperplasia
  • Ovarian Cancer
  • Cervical Cancer
  • Renal Cancer
  • Erectile Dysfunction
  • Urinary Incontinence & Overactive Bladder
  • Sexually Transmitted Diseases
  • Others


  • Anti-Infective
  • Urological
  • Hormonal Therapy Drugs
  • Others


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Why AnalystView



Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.


Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.


Data Accuracy And Reliablity

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials


Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us


We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This